PRA Health Sciences Ready to Navigate RACE Act Requirements for Pediatric Oncology

RALEIGH, N.C., June 18 (Korea Bizwire) — Between 2007-2017, 78 novel adult cancer agents were approved by the U.S. Food and Drug Administration,1 but none of those drugs were researched to determine effectiveness for pediatric cancers. That is about to change on August 18 when the RACE Act – The Research to Accelerate Cures and Equity [...]